-99.1%
MSTZ vs BBIO
+187.7%
-286.9%
-99.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | BBIO | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.5% | +1.8% | +3.7% | +6.4% |
| 7D | -23.6% | -0.5% | -23.0% | -24.1% |
| 30D | -60.7% | -10.1% | -50.6% | -63.2% |
| 3M | -58.3% | +12.4% | -70.7% | -54.8% |
| 6M | -60.0% | +15.9% | -75.9% | -55.3% |
| YTD | -75.2% | -0.5% | -74.7% | -72.6% |
| 1Y | -19.9% | +42.2% | -62.1% | +9.0% |
| All | -99.1% | +187.7% | -286.9% | -98.5% |
Cumulative growth
Daily Returns
Daily percentage return beside BBIO.
Daily Out/Under-Performance
Portfolio return minus BBIO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BBIO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded BBIO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling